Magee v. Paul Revere Life Insurance

172 F.R.D. 647, 1997 U.S. Dist. LEXIS 5461, 1997 WL 244955
District Court, E.D. New York·Decided April 8, 1997·No. No. CV 95-4574(ADS)·Published·Cited by 3 cases

Opinion

MEMORANDUM OF DECISION AND ORDER

SPATT, District Judge:

There being no objections filed to the Max-ch 21, 1997 repox’t and recommendation of United States Magistrate Judge Michael L. Orenstein, it is hereby

ORDERED, that the March 21, 1997 re-pox’t and recommendation of Judge Orenstein is adopted as the opinion of this Court.

SO ORDERED.

REPORT AND RECOMMENDATION

ORENSTEIN, United States Magistrate Judge.

Pending before the Coux't is Defendant’s motion for leave to amend its Answer to add an affinnative defense and three counterclaims. For the reasons set forth below, this Court reports and recommends that the motion be denied.

BACKGROUND

This is a bx’each of contract action brought under the Court’s diversity jurisdiction, 28 U.S.C. § 1332. The gi'avamen of the Complaint is that Defendant breached a policy of disability insurance (the “Policy”) issued to Plaintiff when it ceased making monthly pay[649]*649ments allegedly due and owing Plaintiff. In its defense, Defendant claims that it stopped making payments to Plaintiff only after determining that he was no longer permanently mentally disabled within the meaning of the Policy.

The proffered affirmative defense maintains that Plaintiff intentionally and fraudulently made material misrepresentations in his application for the Policy. The proposed counterclaims all relate to the alleged misrepresentations. Counterclaim I seeks a judgment rescinding the Policy. Counterclaim II seeks restitution, less premiums paid, for some $250,000.00 in benefits paid out to Plaintiff under the Policy. Counterclaim III seeks a declaration that the Policy was void ab initio. Counterclaim IV seeks to recover benefits paid Plaintiff, less premiums, under the theory of unjust enrichment.

The alleged misrepresentations stem from a question on the Policy application concerning past illicit drug use. The question stated as follows:

2. Has any person ever:
a. Except as legally prescribed by a physician, used: cocaine, barbiturates heroin, or any narcotic drug?

In response, Plaintiff cheeked the “NO” box under the column “Proposed Insured”. At Plaintiffs deposition, however, he testified that he had used illicit drugs (including cocaine, hashish and marijuana) numerous times in the 1970’s and 1980’s. (See Mulligan Aff. Ex. D at 337, 452-61, 492-94.) Defendant has submitted an Affidavit from one Sharron DiMartino, the manager in its Individual Underwriting Department who underwrote Plaintiffs Policy. Not surprisingly, Ms. DiMartino avers that, had she known of Plaintiffs past drug use, she would not have approved Plaintiffs application for a disability policy, and that the Underwriting Guidelines would have supported such a decision. (DiMartino Aff. UK 25-26.)

DISCUSSION

I. Standards Governing Motions to Amend

Defendant’s application is governed by Federal Rules of Civil Procedure 13(f) and 15(a). Rule 13(f) authorizes a party to interpose a counterclaim with leave of court when the party “fails to set up [the] counterclaim through oversight, inadvertence, or excusable neglect, or when justice requires.” Rule 15(a) is the provision enabling a party to amend its pleading generally, providing that “leave [to amend] shall be freely given when justice so requires.”1 Consistent with public policy favoring the efficient resolution of disputes on their full merits, both the Supreme Court and the Second Circuit Court of Appeals have adhered to the commands of liberality embodied in Rules 13(f) and 15(a). See, e.g., Nerney v. Valente & Sons Repair Shop, 66 F.3d 25, 28 (2d Cir.1995)(per curiam)(“[T]he Supreme Court has emphasized that amendment should normally be permitted.” (citing Foman v. Davis, 371 U.S. 178, 182, 83 S.Ct. 227, 230, 9 L.Ed.2d 222 (1962))); Ricciuti v. New York City Transit Auth., 941 F.2d 119, 123 (2d Cir.1991)(“[I]t is rare that such leave [to amend] should be denied, especially when there has been no prior amendment.” (citations omitted)).

Nevertheless, it is well-established that leave to amend a pleading may be denied where the proposed amendment would be futile. E.g., Foman, 371 U.S. at 182, 83 S.Ct. at 230; Advanced Magnetics, Inc. v. Bayfront Partners, Inc., 106 F.3d 11, 18 (2d Cir.1997); Acito v. IMCERA Group, Inc., 47 F.3d 47, 55 (2d Cir.1995); In re American [650]*650Express Co. Shareholder Litig., 39 F.3d 395, 402 (2d Cir.1994). An amendment is deemed futile if it fails to state a claim under the principles employed by the Court when deciding on a Rule 12(b)(6) motion to dismiss. See S.S. Silberblatt, Inc. v. East Harlem Pilot Block, 608 F.2d 28, 42 (2d Cir.1979); Gabourel v. Bouchard Transp. Co., 901 F.Supp. 142, 144 (S.D.N.Y.1995). Therefore, in the amendment context, the Court accepts as true all well-pleaded factual allegations set forth in the proposed amendment, DeJesus v. Sears, Roebuck & Co., 87 F.3d 65, 69 (2d Cir.), cert. denied, — U.S. —, 117 S.Ct. 509, 136 L.Ed.2d 399 (1996); Murray v. Miner, 74 F.3d 402, 404 (2d Cir.1996), and views such allegations, as well as all reasonable inferences drawn therefrom, in the light most favorable to the moving party. Harsco Corp. v. Segui, 91 F.3d 337, 341 (2d Cir.1996); Leeds v. Meltz, 85 F.3d 51, 53 (2d Cir.1996); Hernandez v. Coughlin, 18 F.3d 133, 136 (2d Cir.1994). Only if “ ‘it is clear that no relief could be granted under any set of facts that could be proved consistent with the allegations’ ” should the amendment be denied. H.J., Inc. v. Northwestern Bell Tel. Co., 492 U.S. 229, 249-50, 109 S.Ct. 2893, 2906, 106 L.Ed.2d 195 (1988)(quoting Hishon v. King & Spalding, 467 U.S. 69, 73, 104 S.Ct. 2229, 2232, 81 L.Ed.2d 59 (1984)).

II. Application of Futility Doctrine to the Instant Case

The affirmative defense and three counterclaims Defendant seeks to add are predicated upon Plaintiffs alleged misrepresentations regarding past drug use in his application for the Policy. As recognized by Defendant, the threshold obstacle it must overcome in demonstrating a colorable claim of material misrepresentation is the incontestability clause contained in the Policy, which reads as follows:

Free access — add to your briefcase to read the full text and ask questions with AI

Magee v. Paul Revere Life Insurance, 172 F.R.D. 647, 1997 U.S. Dist. LEXIS 5461, 1997 WL 244955 (E.D.N.Y. 1997).

172 F.R.D. 647 (Magee v. Paul Revere Life Insurance) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Bridgeport Music, Inc. v. Universal Music Group, Inc.
248 F.R.D. 408 (S.D. New York, 2008)
Rolfe v. New Britain General Hospital
790 A.2d 1194 (Connecticut Superior Court, 2001)
Robert Goldberger v. Paul Revere Life Insurance Co.
165 F.3d 180 (Second Circuit, 1999)